00:30:17 EST Fri 05 Dec 2025
Enter Symbol
or Name
USA
CA



Rakovina Therapeutics Inc (2)
Symbol RKV
Shares Issued 21,148,039
Close 2025-12-04 C$ 0.12
Market Cap C$ 2,537,765
Recent Sedar Documents

Rakovina Therapeutics debentures amended

2025-12-04 17:30 ET - Private Placement - Debenture

Further to convertible debentures issued pursuant to a private placement originally accepted by the TSX Venture Exchange on June 14, 2023, the exchange has consented to an amendment of the original convertible debentures. The company is not receiving any new additional funds.

Original convertible debentures -- maturity date and underlying warrant expiry:  Nov. 29, 2025

Amended convertible debentures -- maturity date and underlying warrant expiry:  Jan. 28, 2026

Original convertible debentures -- acceleration clause:  not applicable

Amended convertible debentures -- acceleration clause:  not applicable

The amount of aggregate principal outstanding is $1,454,000. All other details of the amended convertible debentures remain unchanged from the original convertible debentures.

For further information, please refer to the company's news releases dated June 30, 2025, and Nov. 28, 2025.

© 2025 Canjex Publishing Ltd. All rights reserved.